Apexian Pharmaceuticals apexianpharma.com


Public list: BIO 2016 (619) Pharma Startups (4732) Cancer Therapeutics (1137)

Apexian Therapeutics, formerly Apex Therapeutics, is a biotechnology company focused on developing novel compounds to treat cancer. The company's lead drug candidate – APX3330 – targets the APE1/Ref-1 redox protein, a molecule found in many cancers, including tumors of the colon, lung, breast, pancreas and others. Its experienced team of research scientists and clinical specialists will commence studies of APX3330 for the treatment of cancer in 2017.

Apexian Therapeutics, formerly Apex Therapeutics, is a biotechnology company focused on developing novel compounds to treat cancer. The company's lead drug candidate – APX3330 – targets the APE1/Ref-1 redox protein, a molecule found in many cance...Show all

Company (Alive / Active)

Phone: 317-684-9196

Fax:

20 N Meridian Street
Suite 801
Indianapolis, 46204
Indiana, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Apexian Pharmaceuticals $14.9M Jul 11, 2018

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Apexian Pharmaceuticals Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
Undisclosed InvestorsOtherUnattributed, Debt
BioCrossroadsVenture CapitalIndianapolis, Indiana, United StatesSeries A
Pearl Street VenturesVenture CapitalIndianapolis, Indiana, United StatesSeries B, Series A - II, Series A
National Cancer InstituteGovernmentBethesda, Maryland, United StatesGrant
Elevate VenturesNon-Profit FoundationIndianapolis, Indiana, United StatesSeries B, Series A - III
See all 5 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Quinone compounds for treating ape1 mediated diseases Oct 23, 2015 Jan 30, 2018 Patent
Quinone compounds for treating ape1 mediated diseases May 25, 2012 Nov 24, 2015 Patent
Quinone compounds for treating ape1 mediated diseases Jan 11, 2018 Application